Infection after medical abortion: a review of the literature

被引:79
作者
Shannon, C [1 ]
Brothers, LP [1 ]
Philip, NM [1 ]
Winikoff, B [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
medical abortion; infection; mifepristone; misoprostol; antibiotics;
D O I
10.1016/j.contraception.2004.04.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medical abortion regimens have become widely used, but the frequency of infection after medical abortion is not well documented. This systematic review provides data on infectious complications after medical abortion. We searched Medline for articles written before July 2003 to determine the frequency of infection after medical abortion up to 26 weeks of gestation. We reviewed all articles and extracted data on the frequency of infection from 65 studies. The frequency of diagnosed and/or treated infection after medical abortion was very low (0.92%7 N = 46,421) and varied among regimens. Results of this review confirm that, with respect to infectious complications, medical abortion is a safe and effective option for first- and second-trimester pregnancy termination. After accounting for regional variations in diagnosis, there is little difference in frequency of infection among the regimens reviewed. Future studies should report clear diagnosis and treatment standards for infection so that more precise information becomes available. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 66 条
[21]   Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortion [J].
Creinin, MD ;
Potter, C ;
Holovanisin, M ;
Janczukiewicz, L ;
Pymar, HC ;
Schwartz, JL ;
Meyn, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (03) :664-669
[22]   Medical abortion with oral methotrexate and vaginal misoprostol [J].
Creinin, MD ;
Vittinghoff, E ;
Schaff, E ;
Klaisle, C ;
Darney, PD ;
Dean, C .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (04) :611-616
[23]   A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion [J].
Creinin, MD ;
Carbonell, JLL ;
Schwartz, JL ;
Varela, L ;
Tanda, R .
CONTRACEPTION, 1999, 59 (01) :11-16
[24]   Methotrexate and misoprostol for early abortion: A multicenter trial .1. Safety and efficacy [J].
Creinin, MD ;
Vittinghoff, E ;
Keder, L ;
Darney, PD ;
Tiller, G .
CONTRACEPTION, 1996, 53 (06) :321-327
[25]  
Davey A, 1997, CONTRACEPTION, V56, P361
[26]   INDUCTION OF ABORTION WITH MIFEPRISTONE (RU-486) AND ORAL OR VAGINAL MISOPROSTOL [J].
ELREFAEY, H ;
RAJASEKAR, D ;
ABDALLA, M ;
CALDER, L ;
TEMPLETON, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) :983-987
[27]   Can women in less-developed countries use a simplified medical abortion regimen? [J].
Elul, B ;
Hajri, S ;
Nguyen, TNN ;
Ellertson, C ;
Ben Slama, C ;
Pearlman, E ;
Winikoff, B .
LANCET, 2001, 357 (9266) :1402-1405
[28]   Termination of second trimester pregnancy with mifepristone and gemeprost -: The clinical experience of 197 consecutive cases [J].
Gemzell-Danielsson, K ;
Östlund, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (08) :702-706
[29]   Medical termination of pregnancy at 63 to 83 days gestation [J].
Gouk, EV ;
Lincoln, K ;
Khair, A ;
Haslock, J ;
Knight, J ;
Cruickshank, DJ .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06) :535-539
[30]  
GUOWEI S, 1994, CONTRACEPTION, V50, P501